# Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects

> **NCT06658964** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jemincare** · enrollment: 48 (estimated)

## Conditions studied

- ADPKD (autosomal Dominant Polycystic Kidney Disease)

## Interventions

- **DRUG:** Cohort 1: JMKX003142 and itraconazole
- **DRUG:** Cohort 2: JMKX003142 and rifampicin

## Key facts

- **NCT ID:** NCT06658964
- **Lead sponsor:** Jemincare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-05
- **Primary completion:** 2024-12-10
- **Final completion:** 2025-03-21
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06658964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06658964, "Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06658964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*